The Mechanisms and Efficacy of New Immunosuppressive Therapies For NMOSD
We explore the efficacy and mechanisms of 3 immunosuppressive therapies that have been approved for use in neuromyelitis optica spectrum disorder (NMOSD).
NMOSD Insights
Contrasting Patterns of Gray Matter Damage Across Subtypes of MS
Investigators strove to quantify imaging patterns of central nervous system damage in MOGAD during the remission stage, and to compare it with NMOSD-AQP4 and MS.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News Briefs
Loading... 
Loading...